Ledger.Open graph →
SEC Form D · filed February 5, 2020

Rgenta Therapeutics, Inc

Offering
$20.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sun S. Linghao · Cambridge, MADirectorTravis S. Wager · Cambridge, MAExecZhiping S. Weng · Cambridge, MADirectorHualin S. Xi · Cambridge, MAExec · DirectorMartin S. Heidecker · Cambridge, MADirectorHaley Ulloa · Baltimore, MDDirectorJoseph Bohm · New York, NYExecOwen E. Meyer · East Setauket, NYExec · DirectorPeter Lamson · New York, NYDirectorGregory Goulder · San Francisco, CADirectorThomas L. Wilkes · Atlanta, GADirectorLynda T. Ausburn · Atlanta, GAExec · DirectorDavid K. Loeffel · Atlanta, GADirectorLauren M. Johnson · Atlanta, GADirectorL. B. Teague · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗